Abstract
Study Design:
Retrospective, database study.
Objectives:
The aim of this study was to investigate incidence and risk factors associated with venous thromboembolic events (VTEs) after lumbar spine surgery.
Methods:
Patients who underwent lumbar surgery between 2007 and 2014 were identified using the Humana within PearlDiver database. ICD-9 (International Classification of Diseases Ninth Revision) diagnosis codes were used to search for the incidence of VTEs among surgery types, patient demographics and comorbidities. Complications including DVT and PE were queried each day from the day of surgery to postoperative day 7 and for periods 0 to 1 week, 0 to 1 month, 0 to 2 months, and 0 to 3 months postoperatively.
Results:
A total of 64 892 patients within the Humana insurance database received lumbar surgery between 2007 and 2014. Overall VTE rate was 0.9% at 1 week, 1.8% at 1 month, and 2.6% at 3 months postoperatively. Among patients that developed a VTE within 1 week postoperatively, 45.3% had a VTE on the day of surgery. Patients with 1 or more identified risk factors had a VTE incidence of 2.73%, compared with 0.95% for patients without risk factors (P < .001). Risk factors associated with the highest VTE incidence and odds ratios (ORs) were primary coagulation disorder (10.01%, OR 4.33), extremity paralysis (7.49%, OR 2.96), central venous line (6.70%, OR 2.87), and varicose veins (6.51%, OR 2.58).
Conclusions:
This study identified several patient comorbidities that were independent predictors of postoperative VTE occurrence after lumbar surgery. Clinical VTE risk assessment may improve with increased focus toward patient comorbidities rather than surgery type or patient demographics.
Keywords: risk factors, venous thromboembolic events, lumbar surgery, retrospective
Introduction
Spinal disorders are one of the most common musculoskeletal problems encountered by physicians in clinical practice today. National statistics collected by the US Department of Health and Human Services show an increased frequency of spinal fusion surgeries, irrespective of spinal level, during the past 20 years.1 Between 2002 and 2009, the annual rates for fusion surgery were greatest for the lumbar spine compared to cervical and thoracic levels, increasing from 45 per 100 000 in 2002 to 72 per 100 000 in 2009.2 Currently, the United States has the highest rate of spine surgery in the world with expenditures for spine-related disorders accounting for $200 billion in total costs from 2002 to 2004.3
Because of the high volume and cost of spine surgery, it is important to investigate and assess postoperative complications in these patients. Venous thromboembolic events (VTEs), including pulmonary emboli (PE) and deep venous thrombosis (DVT), are preventable complications associated with high morbidity and mortality despite advances in diagnosis and treatment. Although approximately 20% of patients present with a PE as the first sign of an underlying DVT, there are inconclusive data on the clinical relevance of an asymptomatic DVT.4,5 The potential for clinically undetected DVTs to develop into life-threatening PEs highlights the importance of physicians to identify, preoperatively, patients who are at an increased risk of thromboembolic events after spine surgery.6
Preoperative risk assessment has been identified as a key component of preventing further increases in the incidence of DVT and PEs.7 Both modifiable and nonmodifiable risk factors including immobility, obesity, advanced age and malignancy have been reported.4,8-10 Thromboembolic prophylaxis is seldom used in spine surgery irrespective of a patient’s preoperative risk due to possible spine epidural hematoma associated with prophylaxis. The American College of Chest Physicians (ACCP) updated guidelines suggest the use of mechanical prophylaxis alone in most patients undergoing spine surgery.11
Current literature regarding the risk factors and incidence associated with thromboembolic events after lumbar surgery is limited. Part of this difficulty may stem from the fact that thromboembolic events are rare complications and therefore require large sample sizes to detect a true difference in incidence between 2 cohorts. Previous database studies on thromboembolic complications after spine surgery have focused on general trends among all surgery types rather than examining incidence and timing specific to lumbar surgery. Therefore, the aim of the present study was to use the data collected in the PearlDiver database to determine if patient- or procedure-related risk factors exist for developing VTEs after lumbar spine surgery. Also, trends, epidemiology, and postoperative timing of VTEs after lumbar surgery were investigated.
Methods
We studied trends in the postoperative incidence of thrombotic complications, including DVT and PE, in patients undergoing lumbar surgery from 2007 to 2014. Institutional review board approval was not required based all the data was deidentified.
Data Sources
Patients who underwent first time isolated lumbar surgery from 2007 to 2014, including any of 5 types of single- or multilevel lumbar procedures (anterior lumbar interbody fusion [ALIF], posterior lumbar interbody fusion [PLIF], posterior lumbar fusion [PLF], discectomy [DISC] and laminectomy [LAMI]), were identified using the PearlDiver insurance database (PearlDiver Technologies, Inc, Fort Wayne, IN, USA). This is a publicly available insurance database which contains records primarily from private insurance Humana’s nationwide member population. Between 2007 and 2014, the PearlDiver database recorded data from 6.3 million to 9.5 million Humana patients (2.1% to 3.0% of the US population) each year.
Procedure and Diagnosis Codes
Lumbar surgery cases from 2007 to 2014 were identified in the PearlDiver database with the use of Current Procedural Terminology (CPT) codes from the American Medical Association and diagnosis codes from the International Classification of Diseases, Ninth Revision (ICD-9-D). Lumbar surgeries were further sub-classified based on CPT codes into 5 types of instrumented and noninstrumented procedures (Appendix A). Patients classified in laminectomy or discectomy groups had these isolated procedures with all fusion surgeries excluded. Database search algorithms were coded to exclude patients with a history of prior lumbar surgery before the analyzed procedure and those with repeat lumbar surgery during the three-month postoperative follow-up period. Data on patient comorbidities was collected using ICD-9-D diagnosis codes. Patient demographics, including age (using 10-year groupings) and gender, were collected. Hospital data collected including location of surgery which was grouped by region in the database (Table 1).
Table 1.
Breakdown of Regions by State.
| Region | States Included |
|---|---|
| Midwest | IA, IL, IN, KS, MI, MN, MO, NE, NO, OH, SD, WI |
| Northeast | CT, MA, ME, NH, NJ, NY, PA, RI, VT |
| South | AL, AR, DC, DE, FL, GA, KY, LA, MD, MS, NC, OK, SC, TN, TX, VA, WV, PR |
| West | AK, AZ, CA, CO, ID, MT, NM, NV, OR, UT, WA, WY, HI |
Complication Codes
Complications, including DVT and PE, were queried each day from the day of surgery to postoperative day 7 and cumulatively for periods 0 to 1 week, 0 to 1 month, 0 to 2 months, and 0 to 3 months postoperatively (Appendix B). Patients were recorded as having a DVT only, DVT and PE, or PE only in each follow-up period.
Drug Codes
PearlDiver generic drug codes, including warfarin, heparin, and low-molecular-weight heparin, were queried for each patient on 2 days prior to surgery, day of surgery, and postoperative day 2.
Statistical Analysis
Data extracted from the PearlDiver database between 2007 and 2014 was pooled for analysis. Summary statistics, including VTE incidence rates and odds ratios (ORs), were calculated for risk factors and demographics. Pearson’s chi-square test for independence was used to analyze significance of risk factors and gender on postoperative risk of VTE. All statistical analyses were performed in SPSS (Version 23.0, IBM Corp, Armonk, NY).
Results
A total of 64 892 patients were found in the PearlDiver database from 2007 to 2014 whom underwent one of the lumbar surgeries and met search criteria. Of these patients, 21 778 underwent laminectomy, 18 960 underwent PLF, 18 261 underwent discectomy, 14 738 underwent PLIF, and 4146 underwent ALIF (Table 2). Obtained data showed an increase in the number of lumbar surgeries performed annually during the 8-year period analyzed from N = 4846 in 2007 to N =12 650 in 2014. Most common age groups identified in the database were aged 60-69 years (31.49%) and 70-79 years (31.49%). Fifty-one percent of patients included in this study were female. Hospital locations were recorded based on region; South (60.0% of patients), Midwest (27.2%), West (10.7%), and Northeast (2.1%). Database identified 58 967 patients (90.87%) with one or more searched preoperative risk factors for a VTE (Table 3). Most common preoperative risk factors included hypertension (74.37%), hypercholesteremia (68.60%), tobacco smoking (31.16%), and obesity (22.40%).
Table 2.
VTE Incidence According to Age, Sex, Hospital Location, and Surgery Type.
| VTE Incidence (%) by Follow-up Period | ||||
|---|---|---|---|---|
| Characteristic | n | 1 Week | 1 Month | 3 Months |
| Total | 64 892 | 0.93 | 1.83 | 2.57 |
| Sex | ||||
| Male | 31 610 | 0.90 | 1.75 | 2.48 |
| Female | 33 282 | 0.97 | 1.91 | 2.66 |
| Age (y) | ||||
| 40-49 | 5369 | 0.50 | 1.19 | 1.56 |
| 50-59 | 9506 | 0.60 | 1.18 | 1.82 |
| 60-69 | 20 434 | 0.95 | 1.79 | 2.53 |
| 70-79 | 20 431 | 1.14 | 2.29 | 3.21 |
| 80-89 | 4446 | 1.61 | 3.01 | 4.03 |
| 90+ | 744 | 1.88 | 2.96 | 3.63 |
| Hospital location | ||||
| Midwest | 17 710 | 1.12 | 2.01 | 2.70 |
| Northeast | 1348 | 1.19 | 2.08 | 2.89 |
| South | 38 916 | 0.82 | 1.70 | 2.42 |
| West | 6918 | 1.06 | 2.08 | 2.98 |
| Surgery type | ||||
| ALIF | 4095 | 1.27 | 2.78 | 3.69 |
| Discectomy | 18 190 | 0.42 | 0.94 | 1.36 |
| Laminectomy | 21 700 | 0.73 | 1.50 | 2.18 |
| PLF | 18 983 | 1.31 | 2.46 | 3.39 |
| PLIF | 14 643 | 1.30 | 2.38 | 3.26 |
Abbreviations: ALIF, anterior lumbar interbody fusion; PLF, posterior lumbar fusion; PLIF, posterior lumbar interbody fusion; VTE, venous thromboembolic event.
Table 3.
VTE Incidence and Odds Ratios at 3-Month Follow-up by Risk Factor.
| VTE Incidence (%) by Follow-up Period | Odds Ratio [CI]a | P a,b | ||||
|---|---|---|---|---|---|---|
| Risk Factor | n | 1 Week | 1 Month | 3 Months | ||
| No risk factor | 5925 | 0.34 | 0.69 | 0.95 | ||
| One or more risk factors | 58 967 | 2.73 | 2.89 [2.21, 3.78] | <.001 | ||
| Diabetes | 20 582 | 1.02 | 2.04 | 3.02 | 1.28 [1.16, 1.42] | <.001 |
| Hypercholesteremia | 44 498 | 0.99 | 1.96 | 2.80 | 1.36 [1.21, 1.52] | <.001 |
| Obesity | 14 538 | 1.18 | 2.43 | 3.48 | 1.51 [1.36, 1.68] | <.001 |
| Varicose veins | 722 | 2.22 | 3.74 | 6.51 | 2.58 [1.91, 3.48] | <.001 |
| Primary coagulation disorder | 2178 | 3.49 | 7.44 | 10.01 | 4.33 [3.73, 5.03] | <.001 |
| Hypertension | 48 258 | 1.07 | 2.08 | 2.94 | 1.02 [0.91, 1.14] | .19 |
| Heart failure | 5146 | 1.50 | 3.24 | 4.53 | 1.89 [1.64, 2.17] | <.001 |
| Arrythmia | 13 709 | 1.51 | 2.77 | 3.98 | 1.81 [1.64, 2.02] | <.001 |
| Pacemaker | 1269 | 1.58 | 3.00 | 4.26 | 1.68 [1.27, 2.21] | <.001 |
| Central venous line | 3509 | 2.62 | 5.16 | 6.70 | 2.87 [2.49, 3.31] | <.001 |
| Myocardial infarction | 1216 | 0.99 | 2.14 | 3.29 | 1.29 [0.94, 1.77] | .11 |
| Malignancy | 2100 | 1.67 | 3.29 | 4.76 | 1.91 [1.55, 2.35] | <.001 |
| Extremity paralysis | 494 | 3.04 | 5.26 | 7.49 | 2.96 [2.11, 4.15] | <.001 |
| Tobacco smoking | 20 223 | 0.83 | 1.62 | 2.33 | 0.87 [0.78, 0.97] | .01 |
Abbreviation: VTE, venous thromboembolic event.
aCalculated using VTE data at 3-month follow-up.
bBased on Pearson’s chi-square test for independence. P values in boldface indicate statistical significance.
Complications and Postoperative Timing
The PearlDiver database identified a total of 1994 VTEs (685 PE and 1259 DVT) in 1667 (2.6%) of these patients at 3-month follow-up. Annual VTE incidences ranged from 2.08% in 2007 to 2.74% in 2014 with all incidences by year differing by less than 1% (Figure 1). Patients with a VTE were recorded as having a DVT only (51.9%), DVT and PE (30.6%) or PE only (17.5%) in the follow-up period. Patients with VTE were recorded by follow-up period; 608 patients (36.5%) at 1 week, 582 new patients at 1 month (34.9%), and 477 new patients (28.6%) at 3-month follow-up. Among patients that developed a VTE within 1 week postoperatively, 45.3% (N = 263) had a VTE on the day of surgery (Figure 2).
Figure 1.
Incidence of venous thromboembolic events (VTEs) at 3-month follow-up based on year.
Figure 2.
Venous thromboembolic event (VTE) complications by postoperative day.
Patients undergoing ALIF had a modestly higher VTE incidence (3.69%) compared with PLIF (3.26%) and PLF (3.39%) at 3-month follow-up (Figure 3). Overall, the lowest VTE incidence amongst lumbar surgeries was found for isolated laminectomy (2.18%) and discectomy (1.36%) procedures.
Figure 3.
Incidence of venous thromboembolic events (VTEs) at 3-month follow-up based on lumbar surgery type.
VTE incidences among age groups ranged from 1.56% in the 40- to 49-year age group to 4.03% in the 80- to 89-year age group. Data on VTE incidence in patients younger than 40 years was not obtained due to the low cohort sizes in these age brackets. No significant differences in incidences of VTE at 3-month follow-up were found between male (2.48%) and female (2.66%) patients (P = .15). Similar incidences of VTE were found among regions at three months follow-up and ranged from 2.49% in the South to 2.93% in the West.
Risk Factors
Patients identified in the database with one or more risk factors had a VTE incidence of 2.73%, compared with 0.95% for patients without risk factors (P < .001). Patients with each of the investigated preoperative risk factors had a higher than average VTE incidence, with the exception of tobacco smoking (Table 3). The risk factors associated with the highest VTE incidence and ORs at 3-month follow-up were primary coagulation disorder (10.01%, OR 4.33), extremity paralysis (7.49%, OR 2.96), central venous line (6.70%, OR 2.87), and varicose veins (6.51%, OR 2.58). All risk factors except for myocardial infarction (P = .11) and hypertension (P = .19) were significantly associated with postoperative VTEs based on Pearson’s chi-square test of independence (P < .001). Tobacco smoking had the lowest VTE incidence (2.33%) and OR (0.87) among searched risk factors and was associated with decreased postoperative VTEs (P = .01).
Drug Prophylaxis
The PealDiver database found a total of 39 patients (0.06%) with VTE prophylaxis 2 days prior to surgery, 17 patients (0.03%) with VTE prophylaxis on day of surgery and 94 patients (1.5%) with VTE prophylaxis on postoperative day 2.
Discussion
We found an overall VTE incidence of 2.57% at 3 months postoperatively in patients undergoing lumbar surgery between 2007 and 2014 in the Humana insurance database. Previous studies have reported VTE incidences after spine surgery from 0.3% to 8.3%7,12-14 and specific to lumbar surgery from 0.2% to 4.3%,15-17 consistent with our results. Hohl et al18 reported a prevalence of developing a VTE was 1.5% in a case control study of 5766 patients whom underwent elective thoracolumbar degenerative spine surgery. Schoenfield et al,19 in a retrospective study of National Surgical Quality Improvement Program data for 27 730 patients reported a VTE rate of 1%. They found body mass index greater than 40 kg/m2 and operative time to be significantly associated with the development of both DVT and PE. Current ACCP guidelines estimate a 0.5% to 1.5% baseline risk for a symptomatic VTE after spine surgery, which increases to 2% in high-risk patients.11 Although representative of a single private insurance database, results of our study indicate these guidelines may underestimate true VTE incidence rates in lumbar spine surgery. Similar incidences of postoperative VTEs were found among procedure type, age group, and gender groupings. Less invasive lumbar procedures, including isolated laminectomy and discectomy, had lower postoperative VTE incidences at all follow-up periods compared with fusion procedures. Interestingly, anterior lumbar interbody fusions were associated with only minor increases in VTE incidence (<1%) compared with posterior fusion procedures.
All searched patient risk factors except for tobacco smoking, hypertension, and myocardial infarction were significantly associated with postoperative VTEs based on Pearson’s chi-squared tests. Four risk factors (varicose veins, extremity paralysis, primary coagulation disorder, central venous line) were associated with VTE incidences greater than 5% at 3-month follow-up. Goz et al12 investigated patients at risk for a VTE after spinal fusion using the Nationwide Inpatient Sample database and found similar independent risk factors for VTE development. Both their overall VTE incidence (0.50%) and incidence rates for similar high-risk comorbidities (0.55%-5.98%) were substantially lower than results found in this study. However, patients were only followed until hospital discharge and therefore follow-up time was significantly shorter than in the present study. These numerical differences may reflect difficulties encountered when directly comparing database studies that are heterogeneous in study design, patient population, and follow-up. Nonetheless, both studies identify a common group of high risk patients that may benefit from stricter prophylaxis and screening measures after spine surgery.
Tobacco smoking was associated with a decreased risk of VTE based on our analysis and had the lowest VTE incidence among comorbidities and risk factors examined.20 Although tobacco use is a well-established risk factor for atherosclerotic disease, its role as an independent risk factor or effect modifier for VTE remains controversial. Several prospective studies have reported smoking to be an independent risk factor,21,22 whereas others failed to detect a significant relationship between smoking and VTE.23,24 A recent meta-analysis found tobacco smoking to be associated with a slightly increased risk of VTE and reported a relative risk for developing a VTE of 1.17 when compared with nonsmokers.20 It is possible that smokers tend to have a lower body mass index on average compared with nonsmokers, which may partially reduce the risk and mask the true association between smoking and VTE.25
However, because of the large-scale nature of this study the underlying etiology for the relationship found between tobacco smoking and VTE incidence cannot be determined.
VTEs that were recorded within 1 week postoperatively in the database were most commonly coded on the day of surgery. Bohl et al26 found, in a retrospective study of 11 807 patients undergoing PLF, that the median day of diagnosis for DVT and PE were 5 and 10 days, respectively. However, their study did not report a breakdown of VTEs by postoperative day making it difficult to directly compare results. Our results indicate that patients undergoing lumbar surgery may be at increased risk of VTE on the day of surgery and could benefit from heightened clinical awareness among spine surgeons and health care providers during this postoperative time period. To the best of our knowledge, this is the first study to examine the incidence of VTEs after lumbar surgery by postoperative day.
PEs and DVTs are thought to represent 2 clinical manifestations of the same disease and it has been widely reported that approximately 90% of symptomatic pulmonary emboli arise from thrombi located in the leg veins.27-29 Our study found that the diagnosis of DVT was present in 63.7% of patients with a postoperative PE after lumbar surgery. Ogelsby et al13 reported, in a study of patients undergoing cervical surgery, that the diagnosis of DVT was present in 21.7% of patients with a postoperative PE. A recent report from the Centers for Disease Control and Prevention demonstrated that DVT was diagnosed in only 28.3% of all admissions with a PE.30 The etiology for the underreporting of DVTs in patients with PEs is multifactorial and likely not specific to spine surgery. First, studies have demonstrated that up to 50% of patients diagnosed with a PE will have no clinical evidence of DVT on ultrasound.31 Furthermore, in patients with a diagnosis of PE there is typically no need to perform further testing to rule out a DVT because it has no effect on treatment or management.
This present study in addition to previous literature has identified multiple independent predictors for developing a VTE after lumbar spine surgery. Future studies using a similar analytical approach are needed to identify effective prophylaxis protocols and screening measures in these high-risk patients. More clinical data is required to determine if strict VTE prophylaxis is warranted in high risk patients despite possible complication of an epidural hematoma.
There are several limitations to this study, including those common to retrospective database studies. Available data was limited to certain demographics without the possibility to search for additional patient characteristics, outcomes, or hospital course information. This limits our ability to determine the impact of postoperative VTE on patient outcomes in lumbar surgery and to explain the underlying etiology of trends found. Because the PearlDiver database is dependent on ICD-9 and CPT coding, it is possible that provider bias or systematic errors in coding may have reduced the accuracy of patient information collected. Zhan et al32 reported the sensitivity of ICD-9 coding for a PE was approximately 74% and for a DVT was approximately 67%. Research has shown that positive predictive values associated with many of the VTE-related ICD-9-CM codes used in this study may be between 75% and 95%.33 The PearlDiver database is composed of records from private insurance companies and does not include Medicare patients, creating potential selection bias. However, results of this study can be used in conjunction with those from other Medicare database studies to gain a better representation of the entire patient population. Lack of data on VTE screening limits our understanding of whether patients were symptomatic at time of diagnosis. DVTs are often clinically silent and PEs may have varying and nonspecific clinical presentations that are challenging to diagnose. Therefore, it is likely that were a number of undiagnosed VTEs not accounted for by this study. The effectiveness of prophylaxis, diagnosis, and treatment measures could not be evaluated; these were outside the scope of this study. Prospective studies may be better designed to evaluate these interventions, but it may be difficult to obtain the sample size for adequate statistical power. Heterogeneity in surveillance and prophylaxis protocols in addition to intraoperative variables, including operative time, blood transfusion, and blood loss cannot be assessed. Despite its limitations, the present study provides useful information to the spine community and hopefully will aid in the design of future studies aimed at evaluating therapeutic and screening measures in high-risk patients undergoing lumbar surgery.
In conclusion, this study identifies several patient comorbidities that were independent predictors of postoperative VTE occurrence after lumbar surgery. Tobacco smoking was not predictive of increased VTE risk, which may reflect increased VTE preventative measures in this patient population. Similar incidences of VTEs were found among procedure type, age group, and gender compared with higher incidences and wider variation when stratifying by searched risk factors. Clinical VTE risk assessment may improve with increased focus toward select high-risk patient comorbidities instead of surgery type or patient demographics based on results of our study. Patients undergoing lumbar surgery may be at an increased risk of postoperative VTE occurrence on the day of surgery and could benefit from heightened surveillance during this time period. We believe our findings on incidence and timing of VTEs after lumbar surgery will provide useful information to clinicians when assessing patient risk in the pre- and postoperative periods.
Appendix A
ALumbar Surgery Procedure Codes.
| Billing Code | Description |
|---|---|
| CPT-22 633 | Arthrodesis, combined posterior or posterolateral technique with posterior interbody technique, including laminectomy and/or discectomy sufficient to prepare interspace (other than for decompression), single interspace, and segment; lumbar |
| CPT-22 634 | Arthrodesis, combined posterior or posterolateral technique with posterior interbody technique including laminectomy and/or discectomy sufficient to prepare interspace (other than for decompression), single interspace and segment; each additional interspace and segment (list separately in addition to code for primary procedure) |
| CPT-22 630 | Arthrodesis, posterior inter body technique, including laminectomy and/or discectomy to prepare interspace (other than for decompression), single interspace; lumbar |
| CPT-22 632 | Arthrodesis, posterior interbody technique, including laminectomy and/or discectomy to prepare interspace (other than for decompression), single interspace; each additional interspace (List separately in addition to code for primary procedure) |
| CPT-22 558 | Anterior approach for lumbar fusion |
| CPT-22 585 | Arthrodesis, anterior interbody technique, including minimal discectomy to prepare interspace (other than for decompression); each additional interspace (list separately in addition to code for primary procedure) |
| CPT-22 612 | Arthrodesis, posterior technique, lumbar (with lateral transverse technique, when performed) |
| CPT-22 614 | Arthrodesis, posterior or posterolateral technique, single level; each additional vertebral segment (list separately in addition to code for primary procedure) |
| CPT-63 030 | Laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy, and/or excision of herniated intervertebral disc; 1 interspace, lumbar |
| CPT-63 035 | Laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy, and/or excision of herniated intervertebral disc; each additional level |
| CPT-63 005 | Laminectomy with exploration and/or decompression of spinal cord and/or cauda equina, without facetectomy, foraminotomy or discectomy (eg, spinal stenosis), 1 or 2 vertebral segments; lumbar, except for spondylolisthesis |
| CPT-63 012 | Laminectomy with removal of abnormal facets and/or pars interarticularis with decompression of cauda equina and nerve roots for spondylolisthesis, lumbar (Gill-type procedure) |
| CPT-63 017 | Laminectomy with exploration and/or decompression of spinal cord and/or cauda equina, without facetectomy, foraminotomy or discectomy (eg, spinal stenosis), more than 2 vertebral segments; lumbar |
| CPT-63 047 | Laminectomy, facetectomy and foraminotomy (unilateral or bilateral with decompression of spinal cord, cauda equina and/or nerve root[s], [eg, spinal or lateral recess stenosis]), single vertebral segment; lumbar |
| CPT-63 056 | Transpedicular approach with decompression of spinal cord, equina and/or nerve root(s) (eg, herniated intervertebral disc), single segment; lumbar (including transfacet, or lateral extraforaminal approach) (eg, far lateral herniated intervertebral disc) |
| CPT-63 087 | Vertebral corpectomy (vertebral body resection), partial or complete, combined thoracolumbar approach with decompression of spinal cord, cauda equina or nerve root(s), lower thoracic or lumbar; single segment |
| CPT-63 102 | Vertebral corpectomy (vertebral body resection), partial or complete, lateral extracavitary approach with decompression of spinal cord and/or nerve root(s) (eg, for tumor or retropulsed bone fragments); lumbar, single segment |
| ICD-9-8051 | Excision of intervertebral disk |
| ICD-9-8106 | Lumbar and lumbosacral fusion of the anterior column, anterior technique (ALIF) |
| ICD-9-8107 | Lumbar and lumbosacral fusion of the posterior column, posterior technique (PLF) |
| ICD-9-8108 | Lumbar and lumbosacral fusion of the anterior column, posterior technique (PLIF/TLIF) |
| ICD-9-8162 | Fusion or refusion of 2-3 vertebrae |
| ICD-9-8163 | Fusion or refusion of 4-8 vertebrae |
| ICD-9-8164 | Fusion or refusion of 9 or more vertebrae |
| ICD-9-0309 | Other exploration and decompression of spinal canal |
Appendix B
Complication Codes.
| Billing Code | Description |
|---|---|
| Deep vein thrombosis | |
| ICD-9-45 340 | Acute venous embolism and thrombosis of unspecified deep vessels of lower extremity |
| ICD-9-45 341 | Acute venous embolism and thrombosis of deep vessels of proximal lower extremity |
| ICD-9-45 342 | Acute venous embolism and thrombosis of deep vessels of distal lower extremity |
| ICD-9-45 382 | Acute venous embolism and thrombosis of deep veins of upper extremity |
| ICD-9-45 384 | Acute venous embolism and thrombosis of axillary veins |
| ICD-9-45 385 | Acute venous embolism and thrombosis of subclavian veins |
| ICD-9-45 386 | Acute venous embolism and thrombosis of internal jugular veins |
| ICD-9-45 387 | Acute venous embolism and thrombosis of other thoracic veins |
| Pulmonary embolism | |
| ICD-9-41 512 | Septic pulmonary embolism |
| ICD-9-41 511 | Iatrogenic pulmonary embolism and infarction |
| ICD-9-41 513 | Saddle embolus pulmonary artery |
| ICD-9-41 519 | Other pulmonary embolism and infarction |
Footnotes
Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: ZB – Xenco Medical (consultancy), AO Spine (consultancy); JCL – Viseon (consulting); JCW – Royalties: Biomet, Seaspine, Amedica, DePuy Synthes; Investments/Options: Fziomed, Promethean, Paradigm Spine, Benvenue, Nexgen, Vertiflex, Electrocore, Surgitech, Expanding Orthopedics, Osprey, Bone Biologics, Pearldiver; Board of Directors: North American Spine Society, North American Spine Foundation, AO Foundation, Cervical Spine Research Society; Fellowship Funding (paid to institution): AO Foundation.
Funding: The author(s) received no financial support for the research, authorship, and/or publication of this article.
References
- 1. Healthcare Cost and Utilization Projectnet. HCUPnet–free health care statistics. https://www.hcup-us.ahrq.gov/news/exhibit_booth/hcupnet_brochure.jsp. Accessed August 9, 2018.
- 2. Rajee SS, Bae HW, Kanim LE, Delamarter RB. Spinal fusion in the United States: analysis of trends from 1998 to 2008. Spine (Phila Pa 1976). 2012;37:67–76. [DOI] [PubMed] [Google Scholar]
- 3. United States Bone and Joint Initiative. The Burden of Musculoskeletal Diseases in the United States. 3rd ed Rosemont, IL: United States Bone and Joint Initiative; 2011. [Google Scholar]
- 4. Brambilla S, Ruosi C, La Maida GA, Caserta S. Prevention of venous thromboembolism in spinal surgery. Eur Spine J. 2004;13:1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest. 2001;119(1 suppl):132S–175S. [DOI] [PubMed] [Google Scholar]
- 6. Fineberg SJ, Oglesby M, Patel AA, Pelton MA, Singh K. The incidence and mortality of thromboembolic events in lumbar spine surgery. Spine (Phila Pa 1976). 2013;38:1154–1159. [DOI] [PubMed] [Google Scholar]
- 7. Wang TY, Sakamoto JT, Nayar G, et al. Independent predictors of 30-day perioperative deep vein thrombosis in 1346 consecutive patients after spine surgery. World Neurosurg. 2015;84:1605–1612. [DOI] [PubMed] [Google Scholar]
- 8. Risk of prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group. BMJ. 1992;305:567–574. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Anderson FA, Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A. The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med. 1992;152:1660–1664. [PubMed] [Google Scholar]
- 10. Goldhaber SZ. Risk factors for venous thromboembolism. J Am Coll Cardiol. 2010;56:1–7. [DOI] [PubMed] [Google Scholar]
- 11. Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 suppl):e227S–e277S. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Goz V, McCarthy I, Weinreb JH, et al. Venous thromboembolic events after spinal fusion: which patients are at high risk? J Bone Joint Surg Am. 2014;96:936–942. [DOI] [PubMed] [Google Scholar]
- 13. Ogelsby M, Fineberg SJ, Patel AA, Pelton MA, Singh K. The incidence and mortality of thromboembolic events in cervical spine surgery. Spine (Phila Pa 1976). 2013;38:E521–E527. [DOI] [PubMed] [Google Scholar]
- 14. Yoshioka K, Murakami H, Demura S, Kato S, Tsuchiya H. Prevalence and risk factors for development of venous thromboembolism after degenerative spinal surgery. Spine (Phila Pa 1976). 2015:40:E301–E306. [DOI] [PubMed] [Google Scholar]
- 15. Nicol M, Sun Y, Niall Craig, Wardlaw D. Incidence of thromboembolic complications in lumbar spine surgery in 1,111 patients. Eur Spine J. 2009;18:1548–1552. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Ferree BA, Wright AM. Deep venous thrombosis following posterior lumbar spinal surgery. Spine (Phila Pa 1976). 1993;18:1079–1082. [DOI] [PubMed] [Google Scholar]
- 17. Cho KJ, Suk SI, Park SR, et al. Complications in posterior fusion and instrumentation for degenerative lumbar scoliosis. Spine (Phila Pa 1976). 2007;32:2232–2237. [DOI] [PubMed] [Google Scholar]
- 18. Hohl JB, Lee JY, Rayappa SP, et al. Prevalence of venous thromboembolic events after elective major thoracolumbar degenerative spine surgery. J Spinal Disord Tech. 2015;28:E310–E315. [DOI] [PubMed] [Google Scholar]
- 19. Schoenfeld AJ, Herzog JP, Dunn JC, Bader JO, Belmont PJ., Jr Patient-based and surgical characteristics associated with the acute development of deep venous thrombosis and pulmonary embolism after spine surgery. Spine (Phila Pa 1976). 2013;38:1892–1898. [DOI] [PubMed] [Google Scholar]
- 20. Cheng Y, Zhi-Hao L, Yao FJ, et al. Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis. PLoS Med. 2013;10:e1001515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Holst AG, Jensen G, Prescott E. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation. 2010;121:1896–1903. [DOI] [PubMed] [Google Scholar]
- 22. Severinsen MT, Kristensen SR, Johnsen SP, Dethlefsen C, Tjønneland A, Overvad K. Smoking and venous thromboembolism: a Danish follow-up study. J Thromb Haemost. 2009;7:1297–1303. [DOI] [PubMed] [Google Scholar]
- 23. Rosengren A, Freden M, Hansson PO, Wilhelmsen L, Wedel H, Eriksson H. Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men. J Thromb Haemost. 2008;6:558–564. [DOI] [PubMed] [Google Scholar]
- 24. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med. 2002;162:1182–1189. [DOI] [PubMed] [Google Scholar]
- 25. Shimokata H, Muller DC, Andres R. Studies in the distribution of body fat. III. Effects of cigarette smoking. JAMA. 1989;261:1169–1173. [PubMed] [Google Scholar]
- 26. Bohl DD, Webb ML, Luksiewicz AM, et al. Timing of complications after spinal fusion surgery. Spine (Phila Pa 1976). 2015;40:1527–1535. [DOI] [PubMed] [Google Scholar]
- 27. Girard P, Sanchez O, Lerover C, et al. Deep venous thrombosis in patients with acute pulmonary embolism: prevalence, risk factors, and clinical significance. Chest. 2005:128:1593–1600. [DOI] [PubMed] [Google Scholar]
- 28. Kearon C. Natural history of venous thromboembolism. Circulation. 2003;107(23 suppl 1):I22–I30. [DOI] [PubMed] [Google Scholar]
- 29. Hyers TM. Venous thromboembolism. Am J Respir Crit Care Med. 1999;159:1–14. [DOI] [PubMed] [Google Scholar]
- 30. Perrier A, Bounameaux H. Cost-effective diagnosis of deep vein thrombosis and pulmonary embolism. Thromb Haemost. 2001;86:475–487. [PubMed] [Google Scholar]
- 31. van Langevelde K, Sramek A, Vincken PW, van Rooden JK, Rosendaal FR, Cannegieter SC. Finding the origin of pulmonary embolism with a total-body magnetic resonance direct thrombus imaging technique. Haematologica. 2013;98:309–315. doi:10.3324/haematol.2012.069195 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Zhan C, Battles J, Chiang YP, Hunt D. The validity of ICD-9-CM codes in identifying postoperative deep vein thrombosis and pulmonary embolism. Jt Comm J Qual Patient Saf. 2007;33:326–331. [DOI] [PubMed] [Google Scholar]
- 33. White RH, Garcia M, Sadeghi B, et al. Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States. Thromb Res. 2010;126:61–67. [DOI] [PubMed] [Google Scholar]



